Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (71-80 of 334) with videos related to

Pageof 34
Sort By:
Advances in Radiation Oncology|December 4, 2023
Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 TrialOrane Lorton, Vérane Achard, Nikolaos Koutsouvelis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison studyPiet Ost, Bruno Speleers, Gert De Meerleer, et al.
Frontiers in Oncology|May 2, 2022
Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate CancerCarole Mercier, Marc Claessens, Bart De Troyer, et al.
European Urology|April 26, 2011
High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year resultsPiet Ost, Nicolaas Lumen, An-Sofie Goessaert, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2019
Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literatureLauren Villeirs, Thomas Tailly, Piet Ost, et al.
The Prostate|January 8, 2014
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancerPiet Ost, Karel Decaestecker, Bieke Lambert, et al.
Physics and Imaging in Radiation Oncology|October 9, 2023
A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancerGeert De Kerf, Michaël Claessens, Fadoua Raouassi, et al.
Journal of Bone Oncology|July 21, 2022
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic reviewRuben Van den Brande, Erwin Mj Cornips, Marc Peeters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?Valérie Fonteyne, Piet Ost, Frank Vanpachtenbeke, et al.
BMC Cancer|May 4, 2017
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trialValérie Fonteyne, Piet Dirix, Sara Junius, et al.
Pageof 34

Showing results (71-80 of 334) with videos related to

Sort By:
Pageof 34
Advances in Radiation Oncology|December 4, 2023
Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 TrialOrane Lorton, Vérane Achard, Nikolaos Koutsouvelis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison studyPiet Ost, Bruno Speleers, Gert De Meerleer, et al.
Frontiers in Oncology|May 2, 2022
Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate CancerCarole Mercier, Marc Claessens, Bart De Troyer, et al.
European Urology|April 26, 2011
High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year resultsPiet Ost, Nicolaas Lumen, An-Sofie Goessaert, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2019
Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literatureLauren Villeirs, Thomas Tailly, Piet Ost, et al.
The Prostate|January 8, 2014
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancerPiet Ost, Karel Decaestecker, Bieke Lambert, et al.
Physics and Imaging in Radiation Oncology|October 9, 2023
A geometry and dose-volume based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancerGeert De Kerf, Michaël Claessens, Fadoua Raouassi, et al.
Journal of Bone Oncology|July 21, 2022
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic reviewRuben Van den Brande, Erwin Mj Cornips, Marc Peeters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?Valérie Fonteyne, Piet Ost, Frank Vanpachtenbeke, et al.
BMC Cancer|May 4, 2017
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trialValérie Fonteyne, Piet Dirix, Sara Junius, et al.
Pageof 34